Literature DB >> 35686264

Gastroschisis Due to Maternal Exposure to Carbimazole in A Term Neonate.

Suzan S Asfour1, Mountasser M Al-Mouqdad2.   

Abstract

Pregnant women with hyperthyroidism need careful management, which is due to the increased risk of maternal and fetal complications. However, safe and effective therapies for hyperthyroidism during pregnancy remain limited. Carbimazole is an anti-thyroid agent and has been used to treat hyperthyroidism. Gastroschisis is a congenital severe abdominal birth defect of the fetus but its etiology remains unclear. Here, we present a case of a female term neonate who developed gastroschisis after being exposed to carbimazole in uteroduring the first and half of the second trimester.
Copyright © 2022, Asfour et al.

Entities:  

Keywords:  carbimazole; gastroschisis; hyperthyroidism; neonate; term

Year:  2022        PMID: 35686264      PMCID: PMC9170418          DOI: 10.7759/cureus.24808

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  12 in total

Review 1.  Development of gastroschisis: review of hypotheses, a novel hypothesis, and implications for research.

Authors:  Marcia L Feldkamp; John C Carey; Thomas W Sadler
Journal:  Am J Med Genet A       Date:  2007-04-01       Impact factor: 2.802

2.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

3.  Birth defects observed with maternal carbimazole treatment: Six cases reported to Nice's Pharmacovigilance Center.

Authors:  D Koenig; A Spreux; S Hiéronimus; R-M Chichmanian; F Bastiani; Patrick Fénichel; F Brucker-Davis
Journal:  Ann Endocrinol (Paris)       Date:  2010-10-12       Impact factor: 2.478

4.  Maternal hyperthyroidism and congenital malformation in the offspring.

Authors:  N Momotani; K Ito; N Hamada; Y Ban; Y Nishikawa; T Mimura
Journal:  Clin Endocrinol (Oxf)       Date:  1984-06       Impact factor: 3.478

5.  2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis.

Authors:  Douglas S Ross; Henry B Burch; David S Cooper; M Carol Greenlee; Peter Laurberg; Ana Luiza Maia; Scott A Rivkees; Mary Samuels; Julie Ann Sosa; Marius N Stan; Martin A Walter
Journal:  Thyroid       Date:  2016-10       Impact factor: 6.568

6.  Carbimazole-related gastroschisis.

Authors:  Anne-Maëlle Guignon; Michel P Mallaret; Pierre Simon Jouk
Journal:  Ann Pharmacother       Date:  2003-06       Impact factor: 3.154

7.  [Gastroschisis. Management. 50 cases].

Authors:  F Becmeur; M Dreyfus; B Langer; J J Baldauf; R Favre; P Sauvage
Journal:  J Gynecol Obstet Biol Reprod (Paris)       Date:  1995

8.  Prevalence of thyrotoxicosis, antithyroid medication use, and complications among pregnant women in the United States.

Authors:  James J Korelitz; Diane L McNally; Mary N Masters; Sue X Li; Yiling Xu; Scott A Rivkees
Journal:  Thyroid       Date:  2013-06       Impact factor: 6.568

9.  Gastroschisis Following Treatment with High-Dose Methimazole in Pregnancy: A Case Report.

Authors:  Dyah Purnamasari; Susie Setyowati; Em Yunir; Anandhara Indriani Khumaedi; Dante Saksono Harbuwono
Journal:  Drug Saf Case Rep       Date:  2019-05-23

10.  Complexity of gastroschisis predicts outcome: epidemiology and experience in an Australian tertiary centre.

Authors:  Sarah J Melov; Irene Tsang; Ralph Cohen; Nadia Badawi; Karen Walker; Soundappan S V Soundappan; Thushari I Alahakoon
Journal:  BMC Pregnancy Childbirth       Date:  2018-06-11       Impact factor: 3.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.